EU court offers guidance on pharma's role in providing info to patients
This article was originally published in SRA
Executive Summary
The Court of Justice for the European Union has issued rulings in two separate cases that can provide important guidance to pharmaceutical companies on the kind of information that they disseminate about their products within the existing EU regulatory framework that expressly prohibits any advertising of prescription medicines1,2.